Nathan Rice
Stock Analyst at Piper Sandler
(3.09)
# 1,192
Out of 5,147 analysts
61
Total ratings
52.63%
Success rate
11.35%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $134.67 | +11.38% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $41.01 | +17.04% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $42.28 | -0.66% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $31.20 | +12.18% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $79.90 | -7.38% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $152.76 | -45.01% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $190.10 | +3.63% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $26.40 | -65.91% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $656.73 | -33.76% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $289.82 | -19.61% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $44.88 | +84.94% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $19.63 | -23.59% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $134.67
Upside: +11.38%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $41.01
Upside: +17.04%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $42.28
Upside: -0.66%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $31.20
Upside: +12.18%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $79.90
Upside: -7.38%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $152.76
Upside: -45.01%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $190.10
Upside: +3.63%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $26.40
Upside: -65.91%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $656.73
Upside: -33.76%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $289.82
Upside: -19.61%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $44.88
Upside: +84.94%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $19.63
Upside: -23.59%